Buy LL-37 Peptide in Australia
Buy LL-37 in Australia from Macropus Peptides as a priced 5mg research vial. LL-37 is the only human cathelicidin, a 37 amino acid antimicrobial peptide cut from the precursor protein hCAP18, and it is studied in membrane disruption, lipopolysaccharide binding, biofilm and immune cell chemotaxis models. The 5mg vial is listed at a fixed price and ready to order. Each vial holds freeze-dried powder under a crimped seal, labelled with compound, strength, lot number and storage temperature, with a certificate of analysis for every lot. Because LL-37 sticks to glass and ordinary plastics, many laboratories prepare it in low-binding tubes and keep dilute working solutions for as short a time as possible. Add bacteriostatic water to the order and we post it from local Australian stock to any address in the country. For in-vitro laboratory research by adults only, not for human or veterinary use.
| Compound | LL-37 |
|---|---|
| Amount | 5 mg |
| Form | Lyophilised powder |
| Category | Recovery research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
LL-37 5mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy LL-37 Australia: 5mg Vial
Macropus Peptides stocks LL-37 in one priced strength, a 5mg vial of freeze-dried cathelicidin held in our Australian store and ready for checkout. Groups in microbiology and innate immunity buy it for membrane permeabilisation, biofilm and chemotaxis assays; the lot number printed on each label matches a batch certificate.
LL-37 Australia: what the human cathelicidin is
It is the only member of the cathelicidin family of antimicrobial peptides made by humans. It is released from the tail of a larger precursor, hCAP18, coded by the CAMP gene, and takes its name from its length, 37 amino acids, and its first two residues, both leucine. The gene and the processing of the precursor were described in the European Journal of Biochemistry in 1996. Its sequence runs LLGSFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, with a molecular weight near 4,493. Lysines and arginines outnumber the acidic residues, leaving a net charge of about plus six at neutral pH, and there are no cysteines. Neutrophils make it, as do the cells lining skin, gut and airways, and vitamin D signalling switches on the CAMP gene in several of those cell types, one reason the peptide turns up in studies of epithelial defence.
LL-37 peptide: how it works in research
In water the peptide is largely unfolded. On meeting the negatively charged membranes of bacteria it folds into a helix with a water-loving face and a fat-loving face, and that shape lets it disrupt the membrane directly. Beyond that physical action it binds lipopolysaccharide, the outer coat of many bacteria, and acts as a signal to immune cells. A 2000 study in the Journal of Experimental Medicine showed it draws human neutrophils, monocytes and T cells through the receptor then called FPRL1, now FPR2. It also binds extracellular DNA and carries it into plasmacytoid dendritic cells, which then sense that DNA as a danger signal. Laboratories use it to study membrane disruption, biofilms, lipopolysaccharide neutralisation, nucleic acid sensing and immune cell movement, often with a scrambled sequence of the same composition as the control.
LL-37 research: what the cathelicidin studies show
After the 1996 gene paper, a 2006 study in Science linked Toll-like receptor activation in human macrophages to vitamin D driven production of the cathelicidin, and a 2008 paper in the Journal of Biological Chemistry solved its helical structure in lipid micelles alongside KR-12, a twelve residue fragment from the middle of the chain that keeps antibacterial activity. Earlier, a 2001 study in Blood identified proteinase 3 as the enzyme that cuts hCAP18 to release the active peptide outside neutrophils. The 2000 chemotaxis paper used human blood cells in culture. In 2007 a paper in Nature described how the peptide pairs with self DNA to switch on plasmacytoid dendritic cells, opening a line of work on nucleic acid sensing. A 2006 review in Biochimica et Biophysica Acta summarised its structure, membrane interactions and wider biological roles. The record is mainly cell culture, biophysics and animal work, and antimicrobial values vary with test conditions, because salt and serum in the broth both blunt its membrane activity. Each paper is listed in our LL-37 research studies library.
LL-37 vial specifications
| Specification | Detail |
|---|---|
| Compound | LL-37 |
| Amount | 5 mg |
| Form | Lyophilised powder |
| Category | Recovery research |
| Storage | -20 °C, protect from light |
A white cathelicidin cake sits under the crimped seal. The label gives strength, lot and freezer temperature, and the lot is your key to the certificate. The charge that makes the peptide active also makes it cling to glass and untreated plastic, so low-binding tubes suit stock solutions. Store the unmixed cathelicidin frozen at -20 °C away from light before use, and a desiccated box keeps moisture off the stopper.
LL-37 price: 5mg vial and cost per milligram
| Strength | Price | Price per mg |
|---|---|---|
| LL-37 5mg | $99.99 | $20.00 per mg |
The 5mg vial carries a fixed Australian dollar price; the table figure over five is the cost of each milligram. For comparison, Thymosin Alpha-1 comes as a 10mg vial, so the two immune peptides are priced on different fill sizes and per milligram is the fairer yardstick. Broth dilution plates, membrane leakage assays and chemotaxis chambers each draw micrograms rather than milligrams, so one vial can carry a full assay series. Order the vials for a longer programme together so they share one synthesis lot, which matters for a peptide whose behaviour in solution depends on how readily it self-associates.
LL-37 5mg: the single research fill
Five milligrams is the one size we fill, suited to minimum inhibitory concentration plates, membrane assays and chemotaxis runs. A 1 mL make-up concentrates it to 5 mg per mL, the strength most groups keep as stock, and 2.5 mL lowers that to 2 mg per mL. Converted with the 4,493 molecular weight, that 5 mg per mL stock works out near 1.1 millimolar; diluting it a thousandfold into broth gives roughly 1.1 micromolar, a sensible top well for a twofold inhibitory concentration series that then steps down through 0.55, 0.28 and 0.14 micromolar. One vial at that strength fills well over a hundred such plates, since each top well needs only microlitres of stock.
Best place to buy LL-37 Australia
- Sold online at macropuspeptides.com, priced at $99.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
How to get LL-37: ordering online
- Choose the 5mg cathelicidin vial
- Pick a quantity that covers every assay plate
- Put bacteriostatic water in the same cart
- Pay, declaring adult research use
- Ask for the lot certificate once it arrives
LL-37 calculator: water volumes for 5mg
The calculator reports the cathelicidin stock strength for any volume typed in. For reference, 1 mL reaches 5 mg per mL and 2.5 mL reaches 2 mg per mL; other volumes follow as five over the millilitres added, so 2 mL lands at 2.5 and 5 mL at 1 mg per mL. Bacteriostatic water can join the parcel. Freeze and thaw cycles make the helix clump, so hold the solution chilled instead of refreezing it.
Is LL-37 available in Australia
Yes, as a laboratory reagent. The peptide is not a registered therapeutic good and has never been approved by the TGA, ruling out supply for people or animals. The TGA maintains and periodically amends the Poisons Standard, so check how this cathelicidin is classed for your workplace before buying.
LL-37 for sale Australia wide: delivery to laboratories
Parcels are packed in Australia for laboratories nationwide, including Melbourne, Brisbane, Perth and Launceston. Holding the stock locally removes international freight and customs from the route. Related immune peptides include Thymosin Alpha-1 and KPV, both in our recovery research range.
References
- The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. European Journal of Biochemistry. 1996.
- LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. Journal of Experimental Medicine. 2000.
- Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001.
- LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochimica et Biophysica Acta. 2006.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.